Food and Drug Administration
Pharma

Regulatory tracker: Braftovi nabs 1st-line expansion in Europe

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Beyond China and Japan How biopharma is expanding rare disease access across Asia-Pacific

Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific

Brought to you by DKSH
Pharma money pharma money pharma profits Big Pharma sales drug sales

Obesity meds, China drive $2T in projected 2032 drug sales: report

Jun 23, 2026 9:00am
The legacy approach to real-world data is costing you

The legacy approach to real-world data is costing you

Brought to you by HealthVerity
Whistleblower case

Genentech, Novartis accused of Xolair kickback scheme in lawsuit

Jun 23, 2026 8:25am
China flag against blue sky

CARsgen's gastric cancer CAR-T nabs world-first China approval

Jun 22, 2026 12:31pm
More News

US puts German drug spending reform proposals under microscope

Jun 22, 2026 10:14am

Alnylam scolded over promotional activity after Pfizer complaint

Jun 22, 2026 9:46am
Fierce Biotech

A 5-month sprint: Inside Pfizer's $10B deal with Innovent

Jun 21, 2026 10:41pm

Aurobindo must divest 4 drugs to complete Lannett buyout: FTC

Jun 18, 2026 3:45pm